Meyer, M. R. (2016). Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. Analytical and bioanalytical chemistry, 408(13), . https://doi.org/10.1007/s00216-016-9439-6
Chicago Style (17th ed.) CitationMeyer, Markus Robert. "Identification of Main Human Urinary Metabolites of the Designer Nitrobenzodiazepines Clonazolam, Meclonazepam, and Nifoxipam by Nano-liquid Chromatography-high-resolution Mass Spectrometry for Drug Testing Purposes." Analytical and Bioanalytical Chemistry 408, no. 13 (2016). https://doi.org/10.1007/s00216-016-9439-6.
MLA (9th ed.) CitationMeyer, Markus Robert. "Identification of Main Human Urinary Metabolites of the Designer Nitrobenzodiazepines Clonazolam, Meclonazepam, and Nifoxipam by Nano-liquid Chromatography-high-resolution Mass Spectrometry for Drug Testing Purposes." Analytical and Bioanalytical Chemistry, vol. 408, no. 13, 2016, https://doi.org/10.1007/s00216-016-9439-6.